All Insights
Exploring the science, practice, and business of medicine.
Search and Filter Insights
Showing 3 out of 3 Insights
-
Active Filters
-
What’s Next for the Biopharmaceutical Industry and Why Ongoing Learning is Key
The COVID-19 pandemic has led to three key trends in the biopharmaceutical industry: new therapeutic modalities, increased data usage, and stronger collaboration between industry and academia.
-
RWD: Responding to Regulatory and Drug Development Challenges
Rebecca Miksad, MD, MPH, a senior medical director of Flatiron Health, medical oncologist and health outcomes researcher, discusses how real-world data address regulatory and drug development challenges.
-
Leveraging Genetic Insights Throughout the Drug Discovery Pipeline
Robert M. Plenge, MD, PhD, senior vice president in research and early development and head of the immunology, cardiovascular, fibrosis, and global health research team at Bristol Myers Squibb, discusses leveraging genetic insights in drug discovery.
